Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Sales (2020 - 2025)

Fennec Pharmaceuticals filings provide 5 years of Return on Sales readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for Fennec Pharmaceuticals, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2024 to a low of 0.95% in Q1 2021.
  • Median Return on Sales over the past 4 years was 0.0% (2023), compared with a mean of 0.08%.
  • The widest YoY moves for Return on Sales: up 4bps in 2024, down -1bps in 2024.
  • Fennec Pharmaceuticals' Return on Sales stood at 0.95% in 2021, then surged by 100bps to 0.0% in 2023, then grew by 30bps to 0.0% in 2024, then surged by 182bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.